28 February 2020

The WHO Target Product Profiles (TPP) document informs product developers, regulatory agencies, procurement agencies and funders on R&D and public health priorities. It is intended to facilitate the most expeditious development of products addressing the greatest and most urgent public health needs. The development of WHO TPPs follows a standardized procedure and includes a number of steps. These include (i) doing a needs assessment; (ii) constituting a scientific TPP development group (with standard WHO Declaration of Interest procedures); (iii) drafting and sharing an initial draft of the TPP with the development group; (iv) revising, posting and disseminating a new version of the TPP for public consultation for 28 days (with comment form); (v) revising and finalizing the TPP (an additional consultation step may be needed in case of significant disagreement); and (vi) posting and disseminating the final version of the TPP.

Source: WHO
Author(s): WHO
Smart Innovations  

Display your AMR technology / product:

Global AMR Technologies Database

  • Preventive – Diagnostic – Antimicrobial technologies
  • Academia – Research Institutes – Start ups – SMEs – Multinationals
  • Early research <-> near market (max 5)
  • Global reach for funding / co-development / licensing
Display your technology >>
What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!